ArticleBMJ open2021

Study protocol of a phase 1 clinical trial establishing the safety of intrapleural administration of liposomal curcumin: curcumin as a palliative treatment for malignant pleural effusion (IPAL-MPE).

Ashleigh Jean Hocking et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.